Arthurian Life Sciences Investor

Arthurian Life Sciences Ltd was established by Europe’s leading biotech entrepreneur Professor Sir Chris Evans OBE to act as General Partner of the Wales Life Sciences Investment Fund, a £100 million fund and key part of the Welsh Government’s Life Sciences initiative. The Fund will invest in Life Sciences and related medical, pharmaceutical and healthcare companies currently based in Wales, and also in companies from across the UK, Europe and the rest of the world, where such investment will bring meaningful developmental and economic benefit to Wales. The Fund will make initial investments of between £500,000 and £5,000,000, and will preserve capital to provide follow-on investments. Arthurian will spread investments by risk, sub-sector, age or funding requirement and will consider companies of all sizes, both start-ups and mature companies, and will do both early & late stage investments.
Technology: N/A
Industry: Preventive Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2012
Employees Number: 11-50
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Seed, Series B, Series C
Number Of Exits: 4

Visit Website
info@arixbioscience.com
Register and Claim Ownership